Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.5.0.2
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash Flows from Operating Activities:    
Net loss $ (14,138) $ (5,841)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expenses 2,651 2,084
Issuance of common shares - Founders Agreement 14 0
Issuance of common shares for license expenses 0 633
Amortization of debt discount 324 28
Research and development-licenses acquired, expensed 3,060 2,000
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 147 (78)
Other receivables - related party (509) (1)
Accounts payable and accrued expenses 2,669 794
Net cash used in operating activities (5,782) (381)
Cash Flows from Investing Activities:    
Purchase of research and development licenses (3,060) (2,000)
Net cash used in investing activities (3,060) (2,000)
Cash Flows from Financing Activities:    
Proceeds from note payable, net of debt discount 0 2,554
Payment of note payable (2,792) 0
Proceeds from issuance of common stock, net of offering costs of $0 and $1,507, respectively 570 11,068
Net cash (used in) provided by financing activities (2,222) 13,622
Net (decrease) increase in cash (11,064) 11,241
Cash at beginning of period 50,418 0
Cash at end of period 39,354 11,241
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 20 $ 0